31
Chladek Danny W, Gorcyca David E, Harris Louis L: Viral agent associated with the mystery swine disease.. Boehringer Animal Health, March 3, 1993: EP0529584-A2 (18 worldwide citation)

The invention comprises the preparation and characterisation of a viral agent, which simulates "Mystery Swine Disease" and also processes for culturing the viral agent, and processes for attenuating the virus and for vaccine production.


32
David E Junker, Mark D Cochran: Neutralizing GDF8 epitope-based growth enhancing vaccine. Schering Plough Animal Health Corporation, May 13, 2008: US07371726 (16 worldwide citation)

The invention provides new, specific antigenic peptides from the protein GDF8. The invention also provides fusion proteins comprising the new peptides, immunogens and vaccines based on the new peptides and/or fusion proteins, antibodies that specifically bind to the new peptides of GDF8, and methods ...


33
Roosenschoon Pieter Lieuwe, Loosveld Serge Louis: Method and device for automatically observing the behavior of animals.. Nedap, November 17, 1994: EP0624313-A1 (16 worldwide citation)

Method and apparatus for automatically observing the behavior of animals using at least one automatic identification unit. The identification unit can be mounted at several places in a space where domestic animals are housed, for instance the entrance of the milk parlor (14), a feeding station (10,1 ...


34

35
Crooks Michael John: Non-aqueous micellar solutions of various drugs.. Crooks Michael John, May 15, 1991: EP0427582-A2 (15 worldwide citation)

A non-aqueous micellar solution, for use in animal health, of one or more non water-soluble Anthelmintics and or Insect Growth Regulators in a polyethoxylated oil or fat surfactant and one or more co-solvents chosen from a group comprising Dimethyl Sulphoxide (DMSO), N-Methyl Pyrollidone (NMP), Tetr ...


36
Bruno Tocque, Laurent Bracco, Fabien Schweighoffer: Methods and composition for the detection of pathologic events. Exonhit Therapeutics, Kristina Bieker Brady Ph D, Clark & Elbing, April 16, 2002: US06372432 (15 worldwide citation)

The present invention concerns new compositions and methods for the detection of pathological events. It more specifically concerns methods for the detection in vitro of the presence of a pathology or a pathological event in a subject, comprising taking a sample of blood cells from the subject and d ...


37
Norton W Milgram: Use of 1-deprenyl for retention of specific physiological functions. Deprenyl Animal Health, Zarley McKee Thomte Voorhees & Sease, July 6, 1993: US05225446 (14 worldwide citation)

1-Deprenyl and pharmaceutically acceptable analog forms thereof are used at specific dosage levels and frequency of dosage to slow the normal age dependent deterioration of renal function, to provide increased exploratory behavior level of activity at any given age and in order to retard age deterio ...


38
Norton W Milgram: Use of L-deprenyl for retention of specific physiological functions. Deprenyl Animal Health, Zarley McKee Thomte Voorhees & Sease, September 29, 1992: US05151449 (14 worldwide citation)

L-Deprenyl and pharmaceutically acceptable analog forms thereof are used at specific dosage levels and frequency of dosage to slow the normal age dependent deterioration of renal function, to provide increased exploratory behavior level of activity at any given age and in order to retard age deterio ...


39

40
Frank D Marcum: Composition and method for treatment of joint damage. ArthroDynamic Technologies Animal Health Division, Sutherland Asbill & Brennan, February 3, 2009: US07485629 (12 worldwide citation)

The invention provides compositions useful for the treatment and/or prevention of damage to diarthrodial (synovial) joints and, in particular, traumatic synovitis, inflammation of the synovial membrane, and damage to the articular cartilage of the joint. Specifically, provided are compositions speci ...



Click the thumbnails below to visualize the patent trend.